Dietary taboos and storage guidelines while taking larotrectinib

Larotinib(VITRAKVI), this innovative targeted anti-cancer drug provides a new treatment option for patients with NTRK gene fusion solid tumors. However, to ensure the effectiveness of the drug and patient safety, patients need to strictly adhere to some key precautions when using larotrectinib.

Patients need to be particularly cautious when it comes to diet. Because grapefruit and its products may interact with larotrectinib and cause adverse side effects, patients should avoid ingesting grapefruit and its related products to reduce potential risks.

In addition, herbal supplements need to be chosen carefully. Supplements containing St. John's wort, in particular, should be avoided while taking the drug because they may interact with larotrectinib, affect the drug's efficacy or increase the risk of side effects.

Patients also need to follow specific requirements regarding the storage of medications. Larotrectinib capsules should be stored at room temperature, away from moisture and heat sources, to maintain the stability and effectiveness of the drug. Liquid medicines need to be placed in the refrigerator at a temperature between 2°C and 8°C (36°F and 46°F) to avoid freezing. At the same time, patients should note that liquid medicines that are not used within 90 days after opening should be discarded to ensure the freshness and safety of the medicines.

In general, patients need to pay close attention to the above guidelines while using larotrectinib. Following these recommendations will not only ensure that your medications work optimally, but you can also effectively reduce potential risks and side effects. Therefore, before starting larotrectinib, patients should fully understand and follow these precautions to ensure the safety and effectiveness of the treatment. Currently, larotrectinib has both original and affordable generic versions to choose from, and patients can purchase them according to their own needs.